2022
DOI: 10.1016/j.bbadis.2022.166450
|View full text |Cite
|
Sign up to set email alerts
|

BMAL1 modulates smooth muscle cells phenotypic switch towards fibroblast-like cells and stabilizes atherosclerotic plaques by upregulating YAP1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 17 publications
(12 citation statements)
references
References 66 publications
1
11
0
Order By: Relevance
“…75 Gain-of-function studies in mouse endothelial cells and observations in human carotid plaques show that Bmal1 can inhibit atherosclerosis and promote plaque stability by suppressing oxLDL (oxidized-LDL) and ROS accumulation, 76 and in one study, treatment with recombinant Bmal1 decreased total cholesterol in PPARγ Deacetylation Inhibits Atherosclerosis in Aging mice. 77 In humans, Bmal1 is higher in stable plaques than in plaques more vulnerable to rupture, 78,79 and in our findings, plaque necrosis is significantly reduced. Necrotic tissue contributes to plaque instability in humans, and although plaque rupture does not occur in mice, 80 it is a notable observation that holds relevance to human atherosclerosis.…”
Section: Discussionsupporting
confidence: 65%
“…75 Gain-of-function studies in mouse endothelial cells and observations in human carotid plaques show that Bmal1 can inhibit atherosclerosis and promote plaque stability by suppressing oxLDL (oxidized-LDL) and ROS accumulation, 76 and in one study, treatment with recombinant Bmal1 decreased total cholesterol in PPARγ Deacetylation Inhibits Atherosclerosis in Aging mice. 77 In humans, Bmal1 is higher in stable plaques than in plaques more vulnerable to rupture, 78,79 and in our findings, plaque necrosis is significantly reduced. Necrotic tissue contributes to plaque instability in humans, and although plaque rupture does not occur in mice, 80 it is a notable observation that holds relevance to human atherosclerosis.…”
Section: Discussionsupporting
confidence: 65%
“…BMAL1 is found at higher levels in unstable plaques in humans, accompanied by elevated YAP1 and the fibroblast marker FSP1. BMAL1 overexpression promotes the conversion of VSMCs to fibroblast-like cells by transcriptionally upregulating the expression of YAP1 [ 41 ]. A traditional Chinese medicine previously used to treat itchy skin, vertigo, and certain cardiovascular diseases, Furostanol saponins enriched extract (FSEE) of T. terrestris L., has been shown to inhibit the development of atherosclerosis and suppress the proliferation of VSMCs by inhibiting Akt/MEK/ERK signaling [ 42 ].…”
Section: Cardiovascular Diseases Associated With Vsmcs Phenotypic Swi...mentioning
confidence: 99%
“…Interestingly, the circadian clock transcription factor BMAL1, which is essential for normal circadian variations in SMC contraction, was described to promote a phenotypic switch of SMCs towards fibroblast-like cells and to stabilize atherosclerotic plaques [ 90 ]. As shown in Figure S2 SPN, KLF4 and PKR are both under BMAL1 control [ 91 ].…”
Section: Resultsmentioning
confidence: 99%